Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Jade Biosciences, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- −2 vs. Q2 2023
- Shares held
- 28.5M
- −7.64K (0.0%) vs. Q2 2023
- Total value
- $386.3M
- −$102.0M (−20.9%) vs. Q2 2023
- New holders
- 2
- 22 more added
- Sold out
- 4
- 12 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 213 | $2.89K | 0.00% | −3,111−93.6% | Reduced |
| Metropolitan Life Insurance Co | 701 | $9.51K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 772 | $10.5K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,400 | $19.0K | 0.00% | +520+59.1% | Added |
| Tower Research Capital LLC (TRC) | 1,440 | $19.5K | 0.00% | +532+58.6% | Added |
| Amalgamated Bank | 1,535 | $21.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,254 | $30.6K | 0.00% | −1,946−46.3% | Reduced |
| STRS Ohio | 2,300 | $31.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 3,846 | $52.2K | 0.00% | +440+12.9% | Added |
| New York State Common Retirement Fund | 4,318 | $58.6K | 0.00% | +45+1.1% | Added |
| Deutsche Bank AG | 4,985 | $67.6K | 0.00% | 00.0% | Unchanged |
| MetLife Investment Management | 5,228 | $70.9K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 5,579 | $75.7K | 0.00% | +735+15.2% | Added |
| JPMorgan Chase & Co | 7,419 | $100.7K | 0.00% | −651−8.1% | Reduced |
| Legal & General Group Plc | 7,692 | $104.4K | 0.00% | +1,918+33.2% | Added |
| Bank of America Corp | 10,305 | $139.8K | 0.00% | +4,009+63.7% | Added |
| Golden State Equity Partners | 10,530 | $142.9K | 0.04% | 00.0% | Unchanged |
| California State Teachers Retirement System | 11,012 | $149.4K | 0.00% | +1,116+11.3% | Added |
| UBS Group AG | 11,214 | $152.2K | 0.00% | +8,215+273.9% | Added |
| Two Sigma Investments, LP | 11,804 | $160.2K | 0.00% | −18,207−60.7% | Reduced |
| Alliancebernstein L.P. | 12,450 | $168.9K | 0.00% | +730+6.2% | Added |
| Rhumbline Advisers | 13,993 | $189.9K | 0.00% | +1,007+7.8% | Added |
| Ensign Peak Advisors, Inc | 15,000 | $203.6K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 17,644 | $239.4K | 0.00% | +17,644 | New |
| Morgan Stanley | 19,053 | $258.6K | 0.00% | −13,973−42.3% | Reduced |
| Alps Advisors Inc | 20,395 | $276.8K | 0.00% | +2,075+11.3% | Added |
| Dimensional Fund Advisors LP | 20,546 | $278.9K | 0.00% | −4,465−17.9% | Reduced |
| Parkwood LLC | 20,653 | $280.0K | 0.05% | −2,179−9.5% | Reduced |
| Swiss National Bank | 21,201 | $287.7K | 0.00% | +5,000+30.9% | Added |
| Fred Alger Management, LLC | 24,747 | $335.8K | 0.00% | −33,127−57.2% | Reduced |
| Bank of New York Mellon Corp | 27,412 | $372.0K | 0.00% | +180+0.7% | Added |
| Charles Schwab Investment Management Inc | 29,542 | $400.9K | 0.00% | +2,869+10.8% | Added |
| Nuveen Asset Management, LLC | 36,310 | $492.7K | 0.00% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 47,936 | $650.5K | 0.53% | 00.0% | Unchanged |
| Eversept Partners, LP | 50,242 | $681.8K | 0.08% | 00.0% | Unchanged |
| Skandinaviska Enskilda Banken AB (publ) | 50,866 | $690.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 53,365 | $724.2K | 0.00% | +19,978+59.8% | Added |
| Nantahala Capital Management, LLC | 95,000 | $1.29M | 0.16% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 100,000 | $1.36M | 0.51% | +100,000 | New |
| Northern Trust Corp | 110,443 | $1.50M | 0.00% | +22,446+25.5% | Added |
| State Street Corp | 181,504 | $2.46M | 0.00% | −7,370−3.9% | Reduced |
| Ghost Tree Capital, LLC | 201,197 | $2.73M | 1.32% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 249,808 | $3.39M | 0.00% | +46,750+23.0% | Added |
| Octagon Capital Advisors LP | 497,370 | $6.75M | 1.19% | −124,342−20.0% | Reduced |
| FMR LLC | 529,544 | $7.19M | 0.00% | −198,070−27.2% | Reduced |
| Vanguard Group Inc | 599,102 | $8.13M | 0.00% | +75,535+14.4% | Added |
| OUP Management Co., LLC | 603,762 | $8.19M | 18.43% | 00.0% | Unchanged |
| BlackRock Inc. | 682,781 | $9.27M | 0.00% | +60,134+9.7% | Added |
| OrbiMed Advisors LLC | 756,930 | $10.3M | 0.24% | 00.0% | Unchanged |
| Great Point Partners LLC | 1,091,233 | $14.8M | 2.79% | +159,075+17.1% | Added |
| Driehaus Capital Management LLC | 1,187,618 | $16.1M | 0.21% | −6,473−0.5% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,204,867 | $16.4M | 1.09% | +210,009+21.1% | Added |
| Cormorant Asset Management, LP | 1,561,696 | $21.2M | 1.24% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,963,479 | $26.6M | 0.15% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $27.7M | 4.29% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,201,274 | $29.9M | 4.40% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $51.0M | 3.54% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 8,263,982 | $112.1M | 2.21% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −291,938−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −41,803−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −939−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |